ArticleOncology and therapy2025

Clinical Management and Outcomes of Immune-Related Adverse Events During Treatment with Immune Checkpoint Inhibitor Therapies in Melanoma and Renal Cell Carcinoma: A UK Real-World Evidence Study.

Anna Olsson-Brown et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.